Pre-surgery blood levels of leucine-rich alpha-2-glycoprotein 1 identify patients with a high risk of progressing to castration-resistant prostate cancer
The addition of androgen deprivation therapy and pelvic lymph node treatment to prostate bed salvage radiotherapy (NRG Oncology/RTOG 0534 SPPORT): an international, multicentre, randomised phase 3 trial
Diagnostic accuracy of multiparametric magnetic resonance imaging to detect residual prostate cancer following irreversible electroporation – a multicenter validation study
Topographic description of the site of positive mpmri and impact on the risk of positive surgical margins at robot-assisted nerve sparing radical prostatectomy. implications for accurate surgical approaches
Outcomes of salvage robot-assisted radical prostatectomy (s-rarp) post focal ablation for prostate cancer in comparison with primary robot-assisted radical prostatectomy (rarp); a matched analysis
Overall survival in patients with metastatic hormone-sensitive prostate cancer treated with enzalutamide or placebo plus androgen deprivation therapy who had prior local therapy: post hoc analysis of the phase 3 arches trial